Gelteq (GELS) Total Non-Current Liabilities (2023 - 2025)
Gelteq's (GELS) quarterly Total Non-Current Liabilities came in at $34397.3 in Q4 2025, up 22.21% year-on-year from $28145.0 in Q4 2024, and up 39.35% quarter-over-quarter from $24683.6 in Q2 2025.
Gelteq (GELS) Total Non-Current Liabilities (2023 - 2025) Analysis & Trends
Gelteq's Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $34397.3 for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 22.21% year-over-year to $34397.3 in Q4 2025; TTM through Dec 2025 was $34397.3, a 22.21% increase from a year earlier, with the FY2025 full-year figure at $24683.6, down 97.9% from the prior year.
- Total Non-Current Liabilities improved to $34397.3 in Q4 2025 per GELS's latest filing, from $24683.6 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.7 million in Q2 2023 and bottomed at $24683.6 in Q2 2025.
- The 3-year median for Total Non-Current Liabilities is $34397.3 (2025), against an average of $582373.9.
- Biggest YoY gain for Total Non-Current Liabilities was 22.21% in 2025; the steepest drop was 97.9% in 2025.
- Year by year, Total Non-Current Liabilities stood at $1.7 million in 2023, then plunged by 98.3% to $28145.0 in 2024, then gained by 22.21% to $34397.3 in 2025.
- Per Business Quant, the three latest GELS Total Non-Current Liabilities figures stand at $34397.3 (Q4 2025), $24683.6 (Q2 2025), and $28145.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 14.92 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 18.28 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 33.47 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 20.09 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.24 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.26 Bn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | 34,397.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34,397.34 |
| Jun 30, 2025 | 24,683.58 |
| Dec 31, 2024 | 28,144.98 |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2023 | 1.65 Mn |